Healthcare Webinars

The viral vector market, which is crucial for vaccines and gene therapies, is experiencing rapid growth. Essential factors to produce viral vectors needed for clinical trials and commercial manufacturing include scalability in transitioning from process development to commercial production and the simplicity of operating the culture device. Thermo Fisher Scientific's ThermoScientific DynaDrive Single-Use Bioreactor (S.U.B.) is a versatile bioreactor that can cultivate cells used for AAV production across a wide range of volumes, from 50 L to 5,000 L.In this seminar, representatives from both Takara Bio and Thermo Fisher Scientific, key players invigorating the gene therapy market, will explain the features of single-use bioreactors that enable mass manufacturing of AAV vectors. Additionally, they will present case studies with data that highlight the successful viral vector manufacturing process.Speakers: Hideto Chono, Ph.D. serves as the Deputy Head of CDM Business Development Division and General Manager at Takara Bio Inc. He holds a Ph.D. in Agriculture from Kyoto University and has been with Takara since 1992. He specializes in the research, development, and manufacturing of viral vectors, mRNAs, and engineered T-cells.Hiroshi Nagasaki, Ph.D. is a Field Application Scientist at Thermo Fisher Scientific K.K. in Japan. With 13 years of experience at the company, Hiroshi leads a team of Field Application Scientists specializing in BioProduction. He holds a Ph.D. in agriculture from Nagoya University. Hiroshi's expertise and leadership have been instrumental in providing support to customers.

Join us for a sponsored webinar featuring Cytovale’s IntelliSep sepsis test where we will talk about how this novel technology is changing the way patients are triaged in the ED, leading to faster, more accurate detection of sepsis and appropriate care. You will learn insights into what makes sepsis so challenging to diagnose and how IntelliSep can help. You will also meet leaders from Our Lady of the Lake Regional Medical Center, including Dr. Hollis O’Neal, who will share the impact that IntelliSep has had on their patients, day-to-day processes, and the organization broadly. For more information, visit our website cytovale.com.Target Audience: Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.Speaker: Hollis (Bud) O'Neal, MD (Associate Professor of Medicine, Louisiana State University Health Sciences Center).

In this webinar, find out how to optimise oncology clinical trials using digital tools to accelerate decision-making.Oncology clinical trials present some of the most complex challenges across clinical research, impacting enrolment, efficiency, and access. Thankfully, our industry is afforded a unique opportunity to address these issues with the evolving regulatory landscape, the burgeoning field of digital health technologies (DHTs), and the increasing adoption of decentralised and digital trial methods.The US Food and Drug Administration (FDA)’s recent guidance on Direct-to-Patient (DTP) approaches, electronic Patient-Reported Outcomes (ePROs), and DHTs paves the way for incorporating patient-centric digital tools into trials.According to PwC, the use of DHTs in clinical trials has grown by 97 percent within the last five years, and Tufts recognises that the appetite for collecting digital endpoints has doubled every three years since 2015.As DHTs begin to help researchers define the new normal, it’s important to have the right strategy to define how you collect the right data to improve efficiency and experience. Learn how top 10 pharmaceutical companies are using a combination of DHTs, ePROs, clinical trial platforms and more, to ease oncology research and drastically reduce timelines. Key learning points- The right questions to ask your team to help define a digital strategy as part of your clinical development programme. - Why the expanded use of digital measures and biomarkers will continue to accelerate clinical development timelines.- How global pharmaceutical companies are benefiting from Medable’s novel approaches and technology to accelerate decision-making in oncology.Speaker: Musaddiq Khan – Vice President, Customer Value – Digital Outcomes & TA Strategy at Medable

Under U.S. critical infrastructure policy coordinated by the U.S. Department of Homeland Security Cybersecurity and Infrastructure Security Agency (CISA), Healthcare is designated among 15 other industry sectors as “critical infrastructure” and is represented by an industry-organized “sector coordinating council (SCC).” The Health Sector Coordinating Council (HSCC) is a public-private partnership working directly with the U.S. Department of Health and Human Services (including FDA) and focused on providing cybersecurity practices, resources, and advocacy specific to the healthcare sector.How might HSCC participation provide value for your organization’s cybersecurity strategy? HSCC mission is to identify systemic cybersecurity threats; collaborate on guidance and policies for mitigating those risks; and promote threat preparedness and incident response awareness and activities across the sector.In this webinar, Greg Garcia, HSCC Executive Director, will provide an overview of the work done by HSCC, review some specific examples of resources produced by working groups, and discuss HSCC’s recently announced 5-year strategic plan.Attendees will:• Understand HSCC objectives, structure, and strategic plan• Recognize the HSCC work products through provided examples• Evaluate if HSCC participation could be valuable to your organization

Join us for an exclusive FREE LIVE webinar where we provide expert insights and practical tips on selecting the best intraoral scanner for your dental practice in 2024. Our industry experts will share valuable knowledge to help you make an informed decision.Webinar Details:- FREE LIVE Webinar- Date: Friday, August 15th, 2024- Time: 1 PM ET- Location: ZoomWhy Attend?• Gain insights from industry experts on the latest scanner technology.• Learn key features to look for when choosing an intraoral scanner.• Understand the benefits and drawbacks of different scanner models.• Get answers to your specific questions in a live Q&A session.• Discover how the right scanner can enhance your dental practice's efficiency and patient care.Who Should Attend?• Dental professionals looking to upgrade their current equipment.• Dentists seeking to stay updated with the latest trends.• Dental practice owners and managers aiming to optimize workflow.• Dental students and educators interested in new technologies.• Anyone involved in the dental industry.Speaker: Dr. Amr Adel, Digital Dentistry Expert, Atomica AI.Don’t miss this opportunity to elevate your practice – register now!

Already, AI is beginning to transform the healthcare industry in profound ways, and rapid advancements are posing new opportunities and challenges for organizational leaders to consider.With so much happening in the AI realm, it can be hard to keep up. In this upcoming webinar, healthcare leaders will recap the current state of affairs, including applications, ethical considerations and integrating AI more deeply into healthcare systems. They'll also share the feasibility of future applications.Key Learning Points:• Current applications of AI in healthcare, real world examples, and how AI can support decision-making processes• The ethical implications and responsibilities that come with integrating AI into healthcare• Strategies and best practices for developing AI frameworks and GenAI's future in healthcarePresenters: Abby Matchett, VP of Digital Strategy, Bounteous; Jonathan Weber, SVP Data & Analytics, Bounteous.

Presenter: Associate Professor Ann Quinton: Medical sonography at CQUniversity Sydney Australia and Senior Research Sonographer at Nepean Hospital, NSW Australia.Ann’s professional interests lie in teaching and performing research, fetal echocardiography, fetal neurosonography, obstetric and gynaecological ultrasound and educating health professionals in safe clinically focussed ultrasound techniques.While volunteering with Radiology Across Borders in 2023 in the Solomon Islands the issue of teaching health practitioners how to scan the placenta and why, to rule out or diagnose placenta praevia, recognise risk factors for accreta and diagnose vasa praevia was appreciated.Three learning outcomes:1. Learn techniques to assess placental position in the second and third trimesters to diagnose placenta praevia.2. Recognise risk factors for placenta accreta.3. Recognise and diagnose vasa praevia.

Watch our webinar with Nyrada, featuring CEO James Bonnar.The webinar will commence with a presentation, followed by a live Q&A with the audience, providing you the opportunity to ask James any questions about NYR that you may have.Key topics:• Nyrada's brain injury program and its core technology• Non-dilutive funding opportunities• Success in the Phase I trial• Upcoming plans in the next 12-18 months• Near-term catalysts for the company----------------- Nyrada is a drug development company specialising in novel treatments for diseases where there is an unmet clinical need, or where current treatments are suboptimal. US incorporated, ASX listed, Australia headquartered, Nyrada is pioneering a family of small molecule drugs that target Transient Receptor Potential Cation (TRPC) channels. Its lead program is a first in class neuroprotection therapy for both traumatic brain injury (TBI) and stroke.

Brachytherapy is an integral and irreplaceable treatment for patients with many types of gynecologic cancers. While this treatment is well established and supported in the literature and best practices, resources for nurses and teams have been severely limited and have only recently started to be created. This 90 minute webinar is given from the perspective of a physician and a nurse that specialize in brachytherapy, with an in-depth focus on nursing care for patients receiving gynecologic brachytherapy. Other areas of brachytherapy will also be explored, such as critical factors in coordinating treatment schedules,  bedside care during procedures, pain management and anesthesia considerations, and advice for nurses to train not only their patients but other nurses, team members and healthcare professionals throughout their facility for maximum success. Brachytherapy remains one of the most powerful tools in the treatment of gynecologic cancer, and this webinar will help provide foundational knowledge for anyone wishing to learn more about this incredible  and  invaluable nursing specialty and cancer treatment.Faculty: Kayla Kafka-Peterson, RN, BSN and Puja Venkat, MD.You may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.If you have questions or need assistance, contact education@igcs.org. 

This webinar will be presented by Dr. Vicki Giannopoulos (Senior Clinical Psychologist, Sydney Local Health District Drug Health Services, Royal Prince Alfred Hospital).Vicki Giannopoulos (MPsychol, PhD) is a Senior Clinical Psychologist at Sydney Local Health District Drug Health Service working in treating addictions. Her research is in the area of translational research on evidence-based practice, suicide, clinical supervision and comorbidity management.Key learning outcomesThis webinar will provide attendees with a practical understanding of:• How to identify comorbid depression in patients with substance use disorder• The current evidence-based practice for treating comorbid depression and substance use disorders• Practical treatment strategies for comorbid depression and substance use disorders• The key challenges associated with treating comorbid depression and substance use disorders